View Section: Eyestock Rating
NeuBase Fair Value
O7
O7PA.MU stock is not valued by Eyestock.
The last 12 months ended with a loss, and this does not allow us to estimate the value of the company according to eyestock model
Discover Undervalued Companies
NeuBase Valuation
Price chart is not available
1y
3y
5y
All time
Market price
Current market price
Fair value
Min value
Max value
05.11.2024
Market price:
* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.
NeuBase Therapeutics Inc price metrics
-71.05
Annual return (geometric mean)
102.91
Risk (standard deviation) of returns
β
-0.07
Beta (volatility compared to market)
It means that O7PA.MU stock and the market have an inverse correlation
View Section: Profitability